BG102462U - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
BG102462U
BG102462U BG10246298U BG10246298U BG102462U BG 102462 U BG102462 U BG 102462U BG 10246298 U BG10246298 U BG 10246298U BG 10246298 U BG10246298 U BG 10246298U BG 102462 U BG102462 U BG 102462U
Authority
BG
Bulgaria
Prior art keywords
pharmaceutical composition
acid
medicalpractice
andoptimallyy
andinfectious
Prior art date
Application number
BG10246298U
Other versions
BG464Y1 (en
Inventor
Plamen K Tsvetkov
Evtimija I Velikova
Nadezhda G Tsaneva
Simeon I Stojanov
Stefan K Kafedzhijski
Evgenija K Stojanova
Original Assignee
Farmatsija Ad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmatsija Ad filed Critical Farmatsija Ad
Priority to BG102462U priority Critical patent/BG464Y1/en
Publication of BG102462U publication Critical patent/BG102462U/en
Publication of BG464Y1 publication Critical patent/BG464Y1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The pharmaceutical composition with ascorbic acid is in theform of effervescent tablets and finds application in the medicalpractice for the prevention and treatment of chronic andinfectious diseases as well as a stimulating agent. Thecomposition includes ascorbinic acid (vitamin C) up to 1.000 g andoptimallyy selected quantities of auxiliary substances - citricacid, sodium bicarbonate, polyvinylpyrrolidone, macrogol andcolourant, sweetener and an aromatic component.1 claim\!
BG102462U 1998-05-19 1998-05-19 Pharmaceutical composition BG464Y1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG102462U BG464Y1 (en) 1998-05-19 1998-05-19 Pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG102462U BG464Y1 (en) 1998-05-19 1998-05-19 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
BG102462U true BG102462U (en) 1999-12-30
BG464Y1 BG464Y1 (en) 2001-06-29

Family

ID=3927449

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102462U BG464Y1 (en) 1998-05-19 1998-05-19 Pharmaceutical composition

Country Status (1)

Country Link
BG (1) BG464Y1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20171457A1 (en) * 2016-12-20 2018-06-21 X Ing As Effervescent lozenge

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20171457A1 (en) * 2016-12-20 2018-06-21 X Ing As Effervescent lozenge

Also Published As

Publication number Publication date
BG464Y1 (en) 2001-06-29

Similar Documents

Publication Publication Date Title
IL154888A (en) Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis
GEP20053473B (en) High Potency Dihydroergotamine Compositions
CA2370030A1 (en) Sodium channel blocker compositions and the use thereof
BRPI0414876A (en) pharmaceutical compounds and compositions for the prevention of overdose or abuse and their uses
WO2002078627A3 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
PT1126828E (en) Oral administration of adenosine analogs
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
EP1259240B8 (en) Agents, such as nicotinamide or cadpr for the treatment of skin disorders
ES2036553T3 (en) PHARMACEUTICAL COMPOSITIONS THAT HAVE ANTINEOPLASTIC ACTIVITY.
AU9551201A (en) Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic diseasestates
EP1354602A4 (en) Medicinal compositions containing diuretic and insulin resistance-improving agent
WO2004010946A3 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
AP2002002446A0 (en) Method for administering a phosphodiesterase 4 inhibitor.
WO1999061010A3 (en) Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound
WO2000001415A3 (en) Use of inhibitors of protein kinase c epsilon to treat pain
AU7286194A (en) Pharmaceutical composition for prophylaxis and treatment of premature ejaculation
NZ326345A (en) Composition containing diosgenin
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
BG102462U (en) Pharmaceutical composition
WO2001022958A3 (en) A pharmaceutical composition containing lycopene for stabilising atherosclerotic plaques
GB2356347B (en) Pharmaceutical compositions and their use
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
WO2001054676A3 (en) Formulations for states of dehydration
WO2004028457A3 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption